Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novo Holdings

Novo Holdings
VC INVESTOR TYPE
Active STATUS
61 PROFESSIONALS
347 INVESTMENTS
99 PORTFOLIO
136 EXITS
Description

Founded in 1999, Novo Holdings is a corporate venture arm of the Novo Nordisk Foundation headquartered in Hellerup, Denmark. The firm is the holding company for the Novo Group. The firm seeks to invest in the biotechnology, healthcare and life sciences sectors.

Formerly Known As
Nova A/S
Investor Status
Actively Seeking New Investments
Year Founded
1999
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Real Estate
Venture Capital
Primary Office
  • Tuborg Havnevej 19
  • 2900 Hellerup
  • Denmark

+45 35 00 00 00

Novo Holdings Investments (347)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Tempus 30-May-2019 Later Stage VC 00000 Outcome Management (Healthcare) Generating Revenue 000000 00000000
000000 000000000 28-May-2019 0000 0000000 000.00 Biotechnology Profitable
00000000 06-May-2019 00000 00000 0000 Agricultural Chemicals Generating Revenue 000000 00000 00.0
0000000 000000 10-Apr-2019 00000 00000 0000 Biotechnology Startup 000000 0000000 00
0000 0000000000000 05-Feb-2019 00000 00000 0000 Biotechnology Startup 00000 00000 00.0
00000000 21-Jan-2019 00000 00000 00.000 Biotechnology Clinical Trials - Phase 1 00000 0ü000000 00.0
00000 000000000 00 01-Jan-2019 0000000000 Outcome Management (Healthcare) Generating Revenue 0000000 000000 00
0000000 0000000000 18-Dec-2018 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 0000 0000000 00.0
Camel-IDS 16-Nov-2018 Early Stage VC 000.00 Biotechnology Startup 000000 0ø00000
Mirum Pharmaceuticals 07-Nov-2018 Early Stage VC 00000 Drug Discovery Clinical Trials - Phase 3 0000 0000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Novo Holdings’s full profile, request a free trial.

Novo Holdings Exits (131)

Company Name Exit Date Exit Type Exit Size Status Buyers
Milestone Pharmaceuticals 13-May-2019 IPO 000.00 Completed
0000000 0000000000 22-Jan-2019 000000000000000000 00000 Completed
  • 00000 & 000000
000000 0000000 13-Nov-2018 000000000000000000 00000 Completed
  • 00000 0000000 0000
00-0000 17-Oct-2018 000 00000 Completed
0000000 0000000000 26-Sep-2018 000 0000 Completed
0000000 19-Jul-2018 000 00000 Completed
000 000000000 0000 08-Jun-2018 000000000 00000000 Completed
00 000000000000000 13-Apr-2018 000000000 00000000 Completed
UNUM Therapeutics 29-Mar-2018 IPO 000.00 Completed
iRhythm Technologies 29-Mar-2018 Secondary Transaction - Open Market Completed
To view this investor’s complete exits history, request access »

Novo Holdings Team (98)

Name Title Deals Funds Boards Office Contact
Info
Kasim Kutay Chief Executive Officer 0 0 San Francisco, CA
Peter Haahr Chief Financial Officer & Member of the Management Board 0 Hellerup, Denmark
Morten Beck Jørgensen Managing Director, Financial Investments 0 0 Hellerup, Denmark
Søren Moller Ph.D Managing Partner, Novo Seeds 0 0 0 Hellerup, Denmark
Thomas Dyrberg MD Managing Partner, Novo Ventures 00 0 0 Hellerup, Denmark

34 Former Team Members

You’re viewing 5 of 98 team members. Get the full list »

Novo Holdings Co-Investors (228)

Name With Exits Lead Partner
New Enterprise Associates 9 00
OrbiMed 0 00
Novartis Venture Fund 0 00
Rock Springs Capital 0 0
Vivo Capital 0 0
To view this investor’s complete co-investor history, request access »